Recent findings show renal denervation improves clinical treatment outcomes in resistant hypertension, indicating need for long-term safety data.
Currently, renal denervation is the only technique that may turn into a meaningful clinical treatment. It is effective, has a acceptable safety profile and is relatively easy to implement. Yet, more information is needed regarding long-term safety and effects on hard cardiovascular endpoints such as myocardial infarction and heart failure. All other forms of device-based treatment are not yet sufficiently developed.
No takes yet. Share an insight, caveat, or question.
LEEUW et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: